Federated Hermes, Inc. Mersana Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 183,744 shares of MRSN stock, worth $297,665. This represents 0.0% of its overall portfolio holdings.

Number of Shares

183,744

Previous 185,507 0.95%

Holding current value

$297,665

Previous $372,000 6.72%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.23 - $2.25 $2,168 - $3,966	-1,763 Reduced 0.95%	183,744 $347,000
Q2 2024 Aug 08, 2024	BUY	$2.0 - $4.45 $370,662 - $824,722	185,331 Added 105301.7%	185,507 $372,000
Q1 2024 May 14, 2024	BUY	$2.16 - $5.94 $380 - $1,045	176 New	176 $0
Q3 2023 Nov 13, 2023	SELL	$1.06 - $3.91 $147,608 - $544,479	-139,253 Reduced 99.01%	1,392 $1,000
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $433,186 - $1.34 Million	140,645 New	140,645 $462,000
Q2 2022 Aug 15, 2022	SELL	$2.84 - $5.0 $2.06 Million - $3.62 Million	-723,933 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.74 - $6.63 $1.95 Million - $3.46 Million	521,350 Added 257.35%	723,933 $2.89 Million
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $1.11 Million - $2 Million	202,583 New	202,583 $1.26 Million
Q1 2021 May 13, 2021	SELL	$15.31 - $26.52 $2,832 - $4,906	-185 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$16.84 - $27.59 $4.69 Million - $7.68 Million	-278,330 Reduced 99.93%	185 $5,000
Q3 2020 Nov 12, 2020	BUY	$16.2 - $25.7 $2.67 Million - $4.23 Million	164,709 Added 144.73%	278,515 $5.19 Million
Q2 2020 Aug 13, 2020	BUY	$5.24 - $23.4 $265,133 - $1.18 Million	50,598 Added 80.05%	113,806 $2.66 Million
Q1 2020 May 13, 2020	BUY	$4.41 - $9.28 $278,712 - $586,496	63,200 Added 790000.0%	63,208 $369,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $6.73 $43 - $201	-30 Reduced 78.95%	8 $1,000
Q3 2019 Nov 14, 2019	BUY	$1.54 - $4.2 $58 - $159	38 New	38 $1,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $157M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Mersana Therapeutics, Inc. Transaction History